Selected News & Events
Stealth BioTherapeutics Completes Mid-Cycle Review Meeting on Elamipretide for the Treatment of Barth Syndrome
Stealth BioTherapeutics Announces First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration
Stealth BioTherapeutics’ Barth Syndrome NDA Receives Priority Review Designation
Stealth BioTherapeutics to Present at JMP Citizens Life Sciences Conference
Events Calendar
No events listed at this time.
Contact Us
Stealth BioTherapeutics
123 Highland Ave, Suite 201
Needham, MA 02494
(617) 600-6888
info@stealthbt.com